Botanical and Plant-Derived Drugs Market to Grow by USD 15.89 bn | Technavio

Key Facts

• The botanical and plant-derived drugs market is expected to grow by USD 15.89 bn from 2021 to 2026, progressing at a CAGR of 7.25% during the forecast period, according to Technavio.
• Technavio has announced its latest market research report titled Botanical and Plant-Derived Drugs Market by Type and Geography - Forecast and Analysis 2022-2026 Botanical and Plant-Derived Drugs Market 2022-2026: Scope The botanical and plant-derived drugs market report covers the following areas: Botanical and Plant-Derived Drugs Market size Botanical and Plant-Derived Drugs Market trends * Botanical and Plant-Derived Drugs Market industry analysis Botanical and Plant-Derived Drugs Market 2022-2026: Drivers and Challenges The increase in government initiatives is driving the botanical and plant-derived drugs market growth.
• Botanical and Plant-Derived Drugs Market 2022-2026: Key Highlights CAGR of the market during the forecast period 2022-2026 Detailed information on factors that will assist botanical and plant-derived drugs market growth during the next five years Estimation of the botanical and plant-derived drugs market size and its contribution to the parent market Predictions on upcoming trends and changes in consumer behavior The growth of the botanical and plant-derived drugs market Analysis of the market's competitive landscape and detailed information on vendors * Comprehensive details of factors that will challenge the growth of botanical and plant-derived drugs market vendors Related Reports: New Drug Delivery Systems Market by Route of Administration and Geography - Forecast and Analysis 2022-2026 Non-small Cell Lung Cancer Drugs Market by Product and Geography - Forecast and Analysis 2022-2026 Botanical And Plant-Derived Drugs Market Scope Report Coverage Details Page number 120 Base year 2021 Forecast period 2022-2026 Growth momentum & CAGR Accelerate at a CAGR of 7.25% Market growth 2022-2026 USD 15.89 billion Market structure Fragmented YoY growth (%) 7.02 Regional analysis Asia, Europe, North America, and Rest of World (ROW) Performing market contribution Asia at 45% Key consumer countries US, UK, Germany, Japan, and China Competitive landscape Leading companies, competitive strategies, consumer engagement scope Companies profiled Bayer AG, Boehringer Ingelheim International GmbH, Dr. Willmar Schwabe GmbH and Co. KG, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Jazz Pharmaceuticals Plc, Johnson and Johnson Inc., Merck KGaA, Mitsubishi Chemical Corp., Novartis AG, Pierre Fabre SA, Protalix Biotherapeutics Inc., Quintis (Australia) Pty Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Tilray Inc., and Verdure Sciences Inc. Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period, Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
• Table Of Contents : Executive Summary Market overview Market Landscape Market ecosystem Market Sizing Market definition Market segment analysis Market size 2021 Market outlook: Forecast for 2021-2026 Five Forces Analysis Five forces summary Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition Market Segmentation by Product Market segments Comparison by Product Plant derived drugs - Market size and forecast 2021-2026 Botanical drugs - Market size and forecast 2021-2026 Market opportunity by Product Customer Landscape Customer landscape Geographic Landscape Geographic segmentation Geographic comparison Asia - Market size and forecast 2021-2026 Europe - Market size and forecast 2021-2026 North America - Market size and forecast 2021-2026 Rest of World (ROW) - Market size and forecast 2021-2026 US - Market size and forecast 2021-2026 Japan - Market size and forecast 2021-2026 China - Market size and forecast 2021-2026 UK - Market size and forecast 2021-2026 Germany - Market size and forecast 2021-2026 Market opportunity by geography Drivers, Challenges, and Trends Market drivers Market challenges Impact of drivers and challenges Market trends Vendor Landscape Overview Vendor landscape Landscape disruption Industry risks Vendor Analysis Vendors covered Market positioning of vendors Bayer AG Boehringer Ingelheim International GmbH GlaxoSmithKline Plc Jazz Pharmaceuticals Plc Johnson and Johnson Inc. Merck KGaA Mitsubishi Chemical Corp. Novartis AG Pierre Fabre SA Sanofi SA Appendix Scope of the report Inclusions and exclusions checklist Currency conversion rates for US$ Research methodology List of abbreviations About Us Technavio is a leading global technology research and advisory company.

Click To Read Full Article